Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01832714
Other study ID # NKI-W81XWH-12-C-0205
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2013
Est. completion date November 2015

Study information

Verified date July 2019
Source Neuro Kinetics
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is designed to evaluate the use of a collection of tests that measure the eye response, balance, oculomotor and reaction time tests to aid in the diagnosis of mTBI. The tests use highly precise measurement tools to assess various neurologic functions. (For example, high-speed cameras to record eye movement, high-end motors to precisely spin and move the subject, comprehensive analysis to stitch together the stimulus and the response.)

Hypotheses:

1. A battery of oculomotor, vestibular and reaction time tests will generate variables that when properly weighted and run through a given multi-variant analysis, will separate the subjects into one of two groups, mTBI or not-mTBI.

2. A battery of neurologic assessment tests including reaction time, vestibular and oculomotor tests taxing a range of neurologic functions and executed using one or more of the I-Portal® family of devices, will generate responses that, when used by a trained physician, can aid in the diagnosis of an mTBI.


Description:

The study uses a prospective, between-subjects design comparing an Investigational (mTBI) Group to a Control Group. The Investigational Group includes SM who had been diagnosed with an mTBI. The Control Group consists of SM who do not have clinical symptoms consistent with mTBI. There will be 90 participants in each group, for a target total of 180 study participants

Existing mTBI evaluation tools will be used to qualify the type and severity of a patient's mTBI symptoms. After the volunteer has been assessed by a physician, the following questionnaires and screening tools will be administered:

- Demographic, included control and patient demographics, education, military service, see Appendix A;

- History of health problems and treatments included medication and mTBI history and stress level before testing, including page 1 of MACE, see Appendix B; History of health problems and treatments included medication and mTBI history and stress level before testing, including page 1 of MACE, used for seconds and third tests only, see Appendix B1;

- Glasgow Coma Scale, use only in 24 hrs after accident, see Appendix C;

- Functional Gait Assessment(FGA) - This is an assessment where the individual is asked to perform ten gait tasks. Each gait task is scored by a trained observer on a 0-3 scale (with 0 being could not perform and 3 being performed well). The individual will end up with a total FGA of between 0-30. The test is very sensitive for demonstrating balance dysfunction and improvement.(see Appendix D)

- Trail Making Test (TMT) - This test is a cognitive test in which subjects use a pencil to draw a line between an ordered series of letters or letters/numbers on a paper. Subjects are instructed to follow the appropriate order without lifting the pencil from the paper. Time to completion is a sensitive measure of cognitive performance. (see Appendix E)

- Dizziness Handicap Inventory,(DHI)-This validated questionnaire is commonly used by clinicians to qualify and quantify symptoms associated with dizziness, light-headedness, vertigo, migraine associated dizziness, and to assist with identifying complaints of dizziness related to anxiety, depression, post-traumatic-stress disorder, etc. This tool will capture subjective symptoms associated with mTBI prior to completing the objective measures (see Appendix F)

Device will be comprehensive oculomotor/ neuro-otologic testing system. System components:

- Motorized Chair that can move in up to 3 axis

- Full field Optokinetic stimulus

- Pursuit Trackerâ„¢ - laser target generator

- Isolation enclosure

- Patient monitoring and communication technology

FDA classification: The NOTC is covered under an FDA 510K, and certified to standards 60601-1, 60601-1-1, 60601-1-2, and 60601-1-4.

Modifications to approved device:

Included by manufacturer:

1. A new function to existing buttons for reaction time test

2. Audio stimulus for audio reaction time test

3. 2 stationary LED's installed inside enclosure ceiling for crHIT test

Investigational software which incorporates newly defined oculomotor and reaction time tests designed to investigate mTBI will be installed on the device.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date November 2015
Est. primary completion date August 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 45 Years
Eligibility Inclusion criteria for all subjects (Control and mTBI) - Males or females from 19 - 45years of age and of all races.

Additional Inclusion criteria for mTBI Subjects

- Diagnosed with traumatic brain injury utilizing 2007 DoD Standard diagnosis of

- 1) Exposed to an event,

- 2) Suffered alteration or loss of consciousness secondary to the event, and

- 3) Had a sequelae from the event.

Exclusion criteria for all subjects (Control and mTBI)

- Brain injury resulting from a penetrating wound to the head, neck, face or brain (to include gunshot wounds)

- Presence of severe aphasia

- Persons whom have had an mTBI within the prior month and are symptomatic.

- Persons with a previous history of multiple mTBIs and are symptomatic.

- History of neuropsychiatric disorders antedating the head injury (e.g. hypochondriasis, major depression, schizophrenia)

- Pregnancy

- Prior disorders of hearing and balance including:

- Meniere's disease

- Chronic migraine

- Multiple sclerosis

- Vestibular neuritis

- Vestibular schwannoma

- Sudden sensorineural hearing loss

- Cerebrovascular disorders

- Systemic disorders: e.g. chronic renal failure, cirrhosis of the liver, etc.

- Medications which depress the sensorium precluding patient compliance with the testing (considered on a case-by-case basis)

- Previous contraindicating surgeries at the discretion of the study physicians or audiologists

Additional Exclusion criteria for Control Subjects

- Concussion within the last year (12 months)

- Repeated blast exposure

Study Design


Locations

Country Name City State
United States Naval Medical Center San Diego San Diego California
United States Madigan Army Medical Center Tacoma Washington

Sponsors (2)

Lead Sponsor Collaborator
Neuro Kinetics United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Variability of latency in reflexive saccades (ms) Examine the latency of subjects with mTBI with respect to mean latency and standard deviation of control subjects. within 7 days of a concussion event
Primary Variability of latency in reaction time test (ms) Examine the latency of subjects with mTBI with respect to mean latency and standard deviation of control subjects. within 7 days of a concussion event
Primary Variability of error in subjective visual vertical test (degrees) Examine the mean error of subjects with mTBI with respect to mean error and standard deviation of control subjects. within 7 days of a concussion event
See also
  Status Clinical Trial Phase
Recruiting NCT05849064 - Concussion Treatment in Older Adults N/A
Terminated NCT04586179 - A Comparison Between Cardiovascular Exercise Modes Following Sport Related Concussion N/A
Not yet recruiting NCT05943561 - Biomarkers in Concussion
Completed NCT02721537 - Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes N/A
Completed NCT03236389 - Brain Dynamics in Response to Jugular Vein Compression N/A
Completed NCT04560400 - Reverse King-Devick Test and History of Multiple Concussions N/A
Completed NCT03678077 - Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
Recruiting NCT05262361 - Persistent Post-Concussion Symptoms With Convergence Insufficiency N/A
Recruiting NCT05105802 - Mindfulness-Based Intervention for Mild Traumatic Brain Injury N/A
Terminated NCT03123822 - Spectacles Lens in Concussed Kids N/A
Completed NCT04641832 - The Combined Effect of Chronic Cannabis Use and Subconcussive Head Impacts on Brain Health N/A
Completed NCT04074486 - Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
Withdrawn NCT04578743 - Exercise as Concussion Therapy Trial- 2 Phase 2
Completed NCT03671083 - Validation of Brain Function Assessment Algorithm for mTBI/Concussion
Completed NCT03170856 - The Effects of a Sub-maximal Exercise Program on Adolescents Who Sustained a Concussion N/A
Completed NCT05069948 - Delivery of Digital Cognitive Behavioural Therapy Following Concussion N/A
Recruiting NCT03889483 - Neurophysiological Measurements Using the NeuroCatchâ„¢ Platform in Pediatric Concussion N/A
Withdrawn NCT02959294 - Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries Early Phase 1
Recruiting NCT06093295 - Non-invasive Brain Stimulation and Injury Risk Biomechanics N/A
Completed NCT02280304 - Meditation in Veterans With PTSD and Mild TBI N/A